Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Dec;54(1-3):140-51.
doi: 10.1007/s12026-012-8304-8.

Diverse immune evasion strategies by human cytomegalovirus

Vanessa Noriega  1 , Veronika Redmann, Thomas Gardner, Domenico Tortorella
Affiliations
Review

Diverse immune evasion strategies by human cytomegalovirus

Vanessa Noriega et al. Immunol Res. 2012 Dec.

Abstract

Members of the Herpesviridae family have the capacity to undergo both lytic and latent infection to establish a lifelong relationship with their host. Following primary infection, human cytomegalovirus (HCMV) can persist as a subclinical, recurrent infection for the lifetime of an individual. This quiescent portion of its life cycle is termed latency and is associated with periodic bouts of reactivation during times of immunosuppression, inflammation, or stress. In order to exist indefinitely and establish infection, HCMV encodes a multitude of immune modulatory mechanisms devoted to escaping the host antiviral response. HCMV has become a paradigm for studies of viral immune evasion of antigen presentation by both major histocompatibility complex (MHC) class I and II molecules. By restricting the presentation of viral antigens during both productive and latent infection, HCMV limits elimination by the human immune system. This review will focus on understanding how the virus manipulates the pathways of antigen presentation in order to modulate the host response to infection.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Biol Chem. 2008 Feb 15;283(7):4031-43 - PubMed
    1. Nat Immunol. 2008 May;9(5):495-502 - PubMed
    1. Nat Rev Immunol. 2010 Jun;10(6):403-14 - PubMed
    1. Immunity. 2011 Aug 26;35(2):161-8 - PubMed
    1. J Virol. 1994 Jun;68(6):4017-21 - PubMed

Publication types

MeSH terms

Substances